Rosemarie Marchan

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Venues

Journal of experimental & clinical cancer research : CR

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena Keller, Katharina Rohlf, Annika Glotzbach, Gregor Leonhardt, Simon Lüke, Katharina Derksen, Özlem Demirci, Defne Göçener, Mohammad AlWahsh, Jörg Lambert, Cecilia Lindskog, Marcus Schmidt, Walburgis Brenner, Matthias Baumann, Eldar Zent, Mia-Lisa Zischinsky, Birte Hellwig, Katrin Madjar, Jörg Rahnenführer, Nina Overbeck, Jörg Reinders, Cristina Cadenas, Jan G Hengstler, Karolina Edlund, Rosemarie Marchan
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Magdalena Keller, Katharina Rohlf, Annika Glotzbach, Gregor Leonhardt, Simon Lüke, Katharina Derksen, Özlem Demirci, Defne Göçener, Mohammad AlWahsh, Jörg Lambert, Cecilia Lindskog, Marcus Schmidt, Walburgis Brenner, Matthias Baumann, Eldar Zent, Mia-Lisa Zischinsky, Birte Hellwig, Katrin Madjar, Jörg Rahnenführer, Nina Overbeck, Jörg Reinders, Cristina Cadenas, Jan G Hengstler, Karolina Edlund, Rosemarie Marchan
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Magdalena Keller, Katharina Rohlf, Annika Glotzbach, Gregor Leonhardt, Simon Lüke, Katharina Derksen, Özlem Demirci, Defne Göçener, Mohammad AlWahsh, Jörg Lambert, Cecilia Lindskog, Marcus Schmidt, Walburgis Brenner, Matthias Baumann, Eldar Zent, Mia-Lisa Zischinsky, Birte Hellwig, Katrin Madjar, Jörg Rahnenführer, Nina Overbeck, Jörg Reinders, Cristina Cadenas, Jan G Hengstler, Karolina Edlund, Rosemarie Marchan
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Patrick D Gajewski, Stephan Getzmann, Peter Bröde, Michael Burke, Cristina Cadenas, Silvia Capellino, Maren Claus, Erhan Genç, Klaus Golka, Jan G Hengstler, Thomas Kleinsorge, Rosemarie Marchan, Michael A Nitsche, Jörg Reinders, Christoph van Thriel, Carsten Watzl, Edmund Wascher
Impact of Biological and Lifestyle Factors on Cognitive Aging and Work Ability in the Dortmund Vital Study: Protocol of an Interdisciplinary, Cross-sectional, and Longitudinal Study. JMIR research protocols 11 (3) (2022)

Rosemarie Marchan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rosemarie Marchan